In order to provide you with a better browsing experience and to improve our site functionality, we use cookies and other tracking technologies. Detailed information on the use of cookies on our site and how to opt out is provided in our Cookie Policy. By clicking into any content on this site, you consent that we can store and access cookies and other tracking technologies as described in our Cookie Policy.

News Release

March 27, 2023

FUJIFILM India launches CAD EYE™ function for Upper Gastrointestinal diagnosis at the GI Update 2023 in Mysuru

The new CAD EYE™ Upper GI enables early detection of cancer in the Upper Gastrointestinal tract 
India is the second country where the technology is being introduced after Japan

Bengaluru March 27, 2023: FUJIFILM India, a pioneer in healthcare imaging and information systems has launched an upgraded version of “CAD EYE™” for diagnosis in stomach and esophagus. The product was launched in National event “GI Update 2023” at Mysuru. Fujifilm has introduced this technology for the first time outside Japan.

The CAD EYETM is an empowering tool based on Artificial Intelligence Technology which assists Gastroenterologists in early detection and characterization of abnormal growth in Gastrointestinal tract. This is the second chapter to the already existing AI diagnostic technology available for detection in colon.

The newly launched AI technology will work on three different visualization modes: White light, LCI (Linked colour Imaging) and BLI (Blue light Imaging). LCI mode is a combination of light settings which can visually enhance any abnormal lesion and inflammation. BLI mode magnifies the detected growth for better pattern analysis of cells. This technology is designed to solve two major screening problems- Lesion oversight (The lesions are in the view but cannot be detected) and Blind spots (Missing lesions when not in observation range). Landmark Photo Checker is the newest advancement that assists the proper observation of the major landmarks in the stomach. This assists the practitioner to navigate lesions in less time, which might be missed with conventional methods that eventually helps in saving lives.

Speaking about the new launch, Mr. Koji Wada, Managing Director, FUJIFILM India said, “Fujifilm India has always been at the forefront of healthcare innovation. With the launch of the new CAD EYE Upper GI in India, we are expanding our endoscopy portfolio. The aim is to provide superior technological medical facilities that can help save lives and encourage patients to become more engaged in their personal care. In line with our vision to provide the best-in-class technology, our aim is to never stop innovating and working towards making India a healthier place to live in.”

Mr. Dheeraj Chaudhri, Head of Endoscopy Division, Endoscopy Systems Division, FUJIFILM India said, “We are delighted to announce the launch of the CAD EYE Upper GI in India, augmenting our range of endoscopy solutions in the country. We believe that this Technological advancement has the power to transform the diagnosis and make it more precise and time saving for the Health care professionals. With Fujifilm Endoscopic Solutions we aim to strengthen the health standards of the country and empower the gastro fraternity improve patient outcomes with world class technology.

FUJIFILM India has always contributed to making health conditions better in India and ensuring a good lifestyle for its citizens and will continue to do the same. Our vision is to develop technology and create innovative products that lead all of mankind to a healthier and sustainable existence.

About FUJIFILM India:

Fujifilm established in 1934 has believed in Innovation and the creation of new values through leading edge and proprietary technologies. Fujifilm, as a firm believer in innovation, continues to work hard to provide consumers with the best products and services. Beginning as Japan's pioneering photographic film maker, Fujifilm has leveraged its imaging and information technology to become a global presence known for innovation in healthcare, graphic arts, optical devices, highly functional materials, and other high-tech areas. Fujifilm is continuously working towards early detection of disease and generating awareness among the public by conducting awareness programs, for promoting TB and Cancer screening.

Media contact

PR and Media Relations - FUJIFILM India Pvt. Ltd

Abhi Shekhar Singh

Mobile: +91 7669011128